Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study.

Source:http://linkedlifedata.com/resource/pubmed/id/20943374

Download in:

View as

General Info

PMID
20943374